| Cash flow (USD) | Q4 2026 ended May 31, 2026 | Q3 2026 ended Feb 28, 2026 | Q2 2026 ended Nov 30, 2025 | Q1 2026 ended Aug 31, 2025 | Q4 2025 ended May 31, 2025 | Q3 2025 ended Feb 28, 2025 | Q2 2025 ended Nov 30, 2024 | Q1 2025 ended Aug 31, 2024 |
|---|---|---|---|---|---|---|---|---|
| Net income | -11.40M | -8.08M | -6.35M | -10.90M | -6.05M | -4.41M | -10.74M | -12.80M |
| Depreciation and amortization | 5.60M | 5.59M | 5.75M | 6.02M | 5.83M | 6.32M | 6.86M | 6.79M |
| Stock-based compensation | 3.92M | 2.70M | 2.90M | 4.47M | 1.64M | 2.40M | 2.50M | 3.21M |
| Cash from operations | 17.45M | -3.11M | 4.66M | -15.91M | 18.81M | -13.16M | 2.47M | -18.25M |
| Capital expenditure | -413.0K | -1.01M | -422.0K | -731.0K | -777.0K | -1.80M | -797.0K | -1.09M |
| Free cash flow | 17.04M | -4.13M | 4.24M | -16.64M | 18.03M | -14.96M | 1.68M | -19.34M |
| Cash from investing | -1.27M | -1.51M | -1.62M | -1.55M | -2.62M | -3.19M | -1.96M | -2.40M |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | -1.12M | -552.0K |
| Net debt issued | 0 | 0 | 0 | 0 | ||||
| Cash from financing | -108.0K | 621.0K | -92.0K | 143.0K | -5.77M | 7.15M | -1.12M | -509.0K |
| Net change in cash | 16.05M | -3.83M | 2.88M | -17.13M | 11.13M | -9.33M | -916.0K | -21.05M |
From Angiodynamics Inc.'s 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read cash flow or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.